Original Article

Lung Cancer in Young Adults: A Single-Center Experience

Authors: Stuart Jones, BS, Timothy Mullett, MD, Daniel Davenport, PhD, Sibu Saha, MD

Abstract

Objective: This single-center retrospective review examines the unique characteristics of young patients (ages 18 to 40 years) who were diagnosed as having non-small-cell lung cancer (NSCLC) at Markey Cancer Center, the only National Cancer Institute–designated cancer center in the state of Kentucky.

Methods: This retrospective study examines adult patients with NSCLC who were between ages 18 and 40 at diagnosis. Patients diagnosed between 2012 and 2018 were included. The final cohort consisted of 35 patients. The data collected included patient demographic information, tumor topography, clinical stage, cell type, treatment information/dates, metastasis, and survival data.

Results: In total, 36 of 3246 total NSCLC cases treated at Markey Cancer Center from 2012 to 2018 were diagnosed in adults aged 18 to 40 (1.11%); 35 of these 36 patients were included in our cohort. The majority (22; 62.86%) presented at an advanced stage of disease (stage III or IV). Furthermore, our cohort consisted of a strong majority of female patients (24; 68.57%). The most common histological type was adenocarcinoma (14; 40.00%). The 5-year survival rate was 47% (standard error 9%).

Conclusions: Lung cancer is rare in young patients; when present, often it presents at the advanced stage. Despite many diagnostic tools and treatment modalities available, long-term survival remains poor. Our experience showed a small proportion of patients with NSCLC aged 18 to 40 at diagnosis; among this unique patient population, there is a predominance of smokers, women, adenocarcinoma, and advanced disease.
Posted in: Lung Cancer – Clinical Presentation & Diagnosis1

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Centers for Disease Control and Prevention, US Cancer Statistics Working Group. US cancer statistics: data visualizations. https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/AtAGlance/. Published 2019, Accessed February 2, 2021.
 
2. Richards TB, Soman A, Thomas CC, et al. Screening for lung cancer—10 states, 2017. Morb Mortal Wkly Rep 2020;69:201–206.
 
3. Arnold BN, Thomas DC, Rosen JE, et al. Lung cancer in the very young: treatment and survival in the National Cancer Data Base. J Thorac Oncol 2016;11:1121–1131.
 
4. Hsu CH, Tseng CH, Chiang CJ, et al. Characteristics of young lung cancer: analysis of Taiwan’s nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status. Oncotarget 2016;7: 46628–46635.
 
5. Kometani T, Sugio K, Osoegawa A, et al. Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene. Thorac Cancer 2018;9:563–570.
 
6. Christian WJ, Vanderford NL, Mcdowell J, et al. Spatiotemporal analysis of lung cancer histological types in Kentucky, 1995–2014. Cancer Control 2019;26:1–8.
 
7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: Cancer J Clin 2016;66:7–30.
 
8. Liu M, Cai X, Yu W, et al. Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old: a population-based study. Oncotarget 2015;6:44963–44970.
 
9. Rich AL, Khakwani A, Free CM, et al. Non-small cell lung cancer in young adults: presentation and survival in the English National Lung Cancer Audit. QJM 2015;108:891–897.
 
10. Jemal A, Miller KD, Ma J, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med 2018;378:1999–2009.
 
11. Liu B, Quan X, Xu C, et al. Lung cancer in young adults aged 35 years or younger: a full-scale analysis and review. J Cancer 2019;10:3553–3559.
 
12. Mack J, Cronin A, Fasciano K, et al. Cancer treatment decision-making among young adults with lung and colorectal cancer: a comparison with adults in middle age. Psychooncology 2016;25:1085–1091.
 
13. Polo V, Zago G, Frega S, et al. Non-small cell lung cancer in a very young woman: a case report and critical review of the literature. Am J Case Rep 2015;16:782–789.
 
14. Wang H, Zhang J, Shi F, et al. Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III. Oncotarget 2017;8: 34923–34934.
 
15. Rao S, Saha S. Timeliness of lung cancer diagnosis and treatment: a single-center experience. Asian Cardiovasc Thorac Ann 2019;27:670–676.